constructed novel NKG2D- CAR-T cells that target NKG2DL expressed on HCC cells and found that NKG2D-CART cells specifically lysed HCC cells with high expression of NKG2DL but did not affect the NKG2DL negative cell line (78). Here, KLRK1 is linked to hepatocellular carcinoma.